Rep. Waxman Becomes Key Legislator On Biopharma Issues With House Flip
This article was originally published in The Pink Sheet Daily
Executive Summary
The congressman will likely support follow-on biologics legislation and other reforms sought by the generic industry as chairman of Government Reform Committee and as a senior member of Energy & Commerce Committee.
You may also be interested in...
Democratic Sen.-Elect Sherrod Brown Has Extensive Healthcare Experience
The Ohio congressman will probably champion generic industry issues as a likely member of the Senate Health Committee.
Democratic Sen.-Elect Sherrod Brown Has Extensive Healthcare Experience
The Ohio congressman will probably champion generic industry issues as a likely member of the Senate Health Committee.
U.S. Policy Missteps Could Send Biotech Overseas, Biogen Idec CEO Warns
China, India and Singapore stand to benefit, Mullen tells Massachusetts biotech investors conference.